4
Changes in Ownership
Janux Therapeutics, Inc. Filed Acc 0001415889-24-024076
Chief Scientific Officer sold 5,000 shares at an average $46.34 ($231,716)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiRaimondo Thomas Chief Scientific Officer | 2024-09-27 | Sale 10b5-1 | −4,325 | $46.21 | $199,840 | 98,613 | D |
| DiRaimondo Thomas Chief Scientific Officer | 2024-09-27 | Sale 10b5-1 | −675 | $47.22 | $31,877 | 97,938 | D |
| Open-market sales · 5,000 sh · avg $46.34 · $231,716 | |||||||
Loading xslF345X05/form4-09272024_110948.xml…